← Biopharmaceutics and Pharmacokinetics Practicals
AUC and Bioequivalence from Given Data for Two Drugs
1. Aim
To study year 4 biopharmaceutics 9 using supervised records and report the supported outcome. Actual case, sample, and result must be entered in the student record.
2. Requirements
Approved de-identified dataset or teaching case, current method, source identifiers, calibration and control records where relevant, graphing or calculation tool, supervisor, and privacy or safety procedure. Record the assigned sample and use approved software. Drug identity, dose, and acceptance criteria are to be recorded from the assigned current monograph or approved college method in the student record.
3. Theory
AUC can be calculated from concentration-time data, but bioequivalence needs an appropriate study design, reference and test products, statistical analysis, and accepted confidence intervals. Two unrelated drugs cannot be declared bioequivalent. The syllabus wording two drugs must be reconciled with the assigned data before interpretation.
4. Procedure
- Confirm the syllabus entry, approved source, ethics or privacy requirements, and method.
- Record actual labels, units, time points, controls, and missing information without guessing.
- Work through the supervised case or dataset: Calculate AUC from the supplied time points with the approved trapezoidal rule. Confirm whether the records are test and reference versions of the same active drug before any bioequivalence analysis.
- Separate raw observations from calculations and check method suitability.
- Use verified formulae and local software only if the full dataset and method support them.
- State the supported result, limitations, and every missing item as Record here.
5. Observation and calculation
| Student record field | Entry |
|---|---|
| Case or product | Record here |
| Method | Record here |
| Observation | Record here |
| Inference | Record here |
| Supervisor check | Record here |
| Outcome | Record here |
Assumed values or observations for practice only: Assumed concentrations at assumed times 0 and 2 hours are 0 and 4 mg/L. Assumed interval AUC = (0+4)/2 × 2 = 4 mg·h/L. This is not a bioequivalence result. All invented inputs and outputs are assumed, not a patient result or laboratory instruction.
6. Output or final result
Provide a labelled AUC and study-design check and supervisor-reviewed conclusion. Record the supervised outcome here.
Teaching-lab safety: Clinical cases must be de-identified and supervised. Human or animal bioavailability work requires prior ethical authorization. No assumed example authorizes dosing or sampling. Software-dependent fitting belongs in the actual lab with its approved program.
This page is a supervised-activity guide; it does not report a completed case.
7. Sources
- PharmacoLearn Pharm.D Year 4 syllabus
- PCI Pharm.D Regulations and Syllabus
- PharmacoLearn syllabus
- Primary method or guidance
Back to Biopharmaceutics and Pharmacokinetics Practicals · All Pharm D Practicals · Pharm D
Theory notes: Pharm D Year 4, 4.5 Biopharmaceutics and Pharmacokinetics
